Biospective Inc. is a specialty Preclinical and Clinical Contract Research Organization (CRO) in North America with particular strengths in CNS diseases and disorders, including Alzheimer’s Disease, Parkinson’s Disease, Multiple Sclerosis, ALS, Schizophrenia, and Depression. Our combination of unique technologies and world-class scientific expertise enables us to provide sponsors with end-to-end solutions for preclinical and clinical studies.
Biospective is an international preclinical contract research organization with state-of-the-art technologies and world-class scientific expertise in animal models, histology, immunohistochemistry (IHC), imaging, and behavioral testing services.
Biospective is a specialty clinical CRO. Our combination of state-of-the-art technologies and scientific clinical expertise enables us to provide end-to-end solutions for clinical studies ranging from single-site exploratory/early phase studies to large-scale and multi-center imaging.